|
||
Cronmolin Dosage |
||
Applies to the following strength(s): 25 mg; 50 mg; 75 mg
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
Outpatients with Mild to Moderate Depression:
-Initial dose: 75 mg orally once a day or in divided doses
-Maintenance dose: 75 to 150 mg/day
-Maximum dose: 225 mg/day
Inpatients with Moderate to Severe Depression:
-Initial dose: 100 to 150 mg orally once a day or in divided doses
-Maintenance dose: 75 to 150 mg/day
-Maximum dose: 225 mg/day
Comments:
-Patients with mild to moderate depression should remain on the initial dose for at least 2 weeks. Titration should gradually increase in 25 mg increments.
-Therapeutic efficacy may be reached by most outpatients at 150 mg/day; however, hospitalized and/or severely depressed patients may require doses up to 225 mg/day.
Uses:
-Treatment of depressive illness in patients with dysthymic disorder/depressive neurosis and major depressive disorder/manic depressive illness, depressed type
-Relief of anxiety related to depression
Outpatients with Mild to Moderate Depression:
-Initial dose: 25 mg orally once a day or in divided doses
-Maintenance dose: 50 to 75 mg/day
Comment:
-Patients over the age of 60 years had a satisfactory response with a maintenance dose of 50 to 75 mg/day; this range should be considered for all patients, and especially in those who cannot tolerate higher doses.
Uses:
-Treatment of depressive illness in patients with dysthymic disorder/depressive neurosis and major depressive disorder/manic depressive illness, depressed type
-Relief of anxiety related to depression
Data not available
Data not available
Pathological neutrophil depression: Discontinue therapy.
US BOXED WARNING:
-SUICIDALITY AND ANTIDEPRESSANT DRUGS: Increased risk of suicidal thinking and behavior has been observed in children, adolescents, and young adults less than 24 years old. Patients should be monitored and closely observed for clinical worsening, suicidality, or unusual changes in behavior. Caregivers and family members should be advised of the need for close observation and communication with the healthcare provider.
Safety and efficacy have not been established in children.
Consult WARNINGS section for additional precautions.
Data not available
Administration advice:
-See manufacturer product information.
Storage requirements:
-See manufacturer product information.
General:
-Clinical improvement may take up to 2 to 3 weeks, though some patients have shown clinical improvement in 3 to 7 days.
Monitoring:
-Leukocyte and WBC with differential, especially in patients who develop fever and/or sore throat
-Vision examination, especially in patients with narrow angle glaucoma and/or increased intraocular pressure
-Clinical worsening or suicidality
Patient advice:
-Warn patients to avoid abrupt discontinuation of this drug.
-Tell patients to immediately report any signs/symptoms of neutropenia/leukopenia, neuroleptic malignant syndrome, or tardive dyskinesia.
-Advise patients, and families/caregivers to monitor and report signs/symptoms of suicidality, and/or unusual behavior immediately to their healthcare provider (e.g., agitation, irritability,anxiety, panic attacks, insomnia, hostility, aggressiveness, impulsivity, akathisia, hypomania/mania).
-Patients should be advised to report all concurrent prescription and nonprescription medications or herbal products they are taking.
-Inform patients that this drug may cause drowsiness, and they should avoid driving or operating machinery until the full effects of the drug are known.
-Patients should be advised to speak to a healthcare provider if they are pregnant, intend to become pregnant, or are breastfeeding.
The following drugs can interact with Cronmolin. Tell your doctor if you are using any of these:
guanethidine (Ismelin);
medicines to treat psychiatric disorders, such as chlorpromazine (Thorazine), mesoridazine (Serentil), or thioridazine (Mellaril);
a sedative such as Valium;
cimetidine (Tagamet); or
phenytoin (Dilantin).
This list is not complete and there may be other drugs that can interact with Cronmolin. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
May interact with the following: alcoholic beverages, barbiturates, and other CNS depressants (response may be exaggerated), adrenergic neuron blocking drugs (Cronmolin may diminish or abolish the antihypertensive effects of these drugs), beta-blockers subject to substantial biotransformation, such as propranolol (concomitant use may increase the plasma concentrations of Cronmolin), sympathomimetic drugs such as noradrenaline, adrenaline, and methylphenidate (Cronmolin may potentiate the cardiovascular effects of these drugs), and Cronmolin may also potentiate the effects of anticholinergic drugs (atropine, biperiden) and levodopa. Drugs that activate hepatic microsomal enzymes, such as barbiturates, phenytoin, oral contraceptives and carbamazepine, may accelerate the metabolism of Cronmolin resulting in decreased antidepressant efficacy. Concomitant administration of phenytoin and Cronmolin may increase serum phenytoin levels resulting in manifestation of the latters side-effects. Concomitant treatment with Cronmolin and major tranquilizers may result in increased plasma levels of Cronmolin, a lowered convulsion threshold, and seizures. The combination of Cronmolin and benzodiazepines may cause increased sedation. Cronmolin should not be administered for a period of at least 14 days after the discontinuation of treatment with MAO-inhibitors due to the potential of severe interactions. Concurrent use of parenteral magnesium sulfate and Cronmolin may result in serious potentiation of CNS depressant effects.
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|